Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis

Схожие документы

• Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
  по: Kumar, Nathella Pavan, et al.
  Опубликовано: (2021)
• Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden
  по: Pavan Kumar, Nathella, et al.
  Опубликовано: (2019)
• Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
  по: Kumar, Nathella Pavan, et al.
  Опубликовано: (2019)
• Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
  по: Kumar, Nathella P., et al.
  Опубликовано: (2018)
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
  по: Kathamuthu, Gokul Raj, et al.
  Опубликовано: (2020)